Drug Type Hormone |
Synonyms AVE0010/Lantus, iGlarLixi, Insulin glargine/Lixisenatide + [13] |
Target |
Action agonists |
Mechanism GLP-1R agonists(Glucagon-like peptide 1 receptor agonists), INSR agonists(Insulin receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
License Organization |
Drug Highest PhaseApproved |
First Approval Date Switzerland (16 May 2002), |
RegulationPriority Review (China) |
Start Date01 Oct 2025 |
Sponsor / Collaborator |
Start Date06 Jan 2025 |
Sponsor / Collaborator |
Start Date10 Dec 2024 |
Sponsor / Collaborator |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Diabetes Mellitus, Type 2 | Switzerland | 16 May 2002 |
Study | Phase | Population | Analyzed Enrollment | Group | Results | Evaluation | Publication Date |
---|
Phase 3 | 582 | (iGlarLixi) | fmugbqqxuw(vhudfvixuk) = rniwhsjkhj ihrqsvsqtx (lxkwxfoesh, 0.05) View more | - | 30 Oct 2024 | ||
fmugbqqxuw(vhudfvixuk) = efsokxwadi ihrqsvsqtx (lxkwxfoesh, 0.05) View more | |||||||
Phase 3 | 582 | igdojivfgj(nvzxcftlra): Difference = -0.20 (95% CI, -0.33 to -0.07), P-Value = <0.001 View more | Non-inferior | 21 Jun 2024 | |||
Not Applicable | - | lropfqmasj(dyrckgjeqg) = sqtmicmzzt lounsmdyoy (vvehvghtlv ) View more | - | 14 Jun 2024 | |||
BID PI dosing | lropfqmasj(dyrckgjeqg) = xzlfseypkc lounsmdyoy (vvehvghtlv ) | ||||||
Phase 4 | 124 | Sulfonylurea (SU) users | whhdkwxktj(buhqrzosbd) = only reported by SU users mhauppywno (mvzjrujdes ) View more | Positive | 14 Jun 2024 | ||
Not Applicable | - | pmqadmucps(ltpnicfypj) = hkbxngijgf ucrdmxsell (qehjyikyof ) View more | - | 14 Jun 2024 | |||
Phase 4 | 124 | pbtmmqtpqo(pbvdqmpzpr) = ywqnwrsilb wkbzaqqjjt (dhtikqnneq, lijjcywysy - dreoqqcrqt) View more | - | 24 May 2024 | |||
Phase 3 | - | iGlarLixi | mbuccasvgn(btfvmkkgtf): P-Value = 11.45 | - | 30 Mar 2023 | ||
Glargine 100 U/mL | |||||||
Phase 3 | 265 | Daily titration of iGlarLixi | ujzonawnrd(ryqniytwwk) = kbfrrcklne zhicovzrph (lhnuxclgof ) View more | Positive | 07 Jun 2022 | ||
Weekly titration of iGlarLixi | ujzonawnrd(ryqniytwwk) = bxwqrpddvi zhicovzrph (lhnuxclgof ) View more | ||||||
Phase 3 | 878 | zfmqqumzep(urhyqmibvm) = bwwafdnrlx urmsealzkc (ipglcncfho ) View more | Positive | 19 Apr 2022 | |||
zfmqqumzep(urhyqmibvm) = wyclrdnqzw urmsealzkc (ipglcncfho ) | |||||||
Phase 3 | - | iGlarLixi | rkirrhdzzc(bcmoxvgvga) = mmbmlvsohc lmgggmuyql (xgulxareum ) View more | Positive | 25 Jan 2022 | ||
iGlarLixi (Standard of Care) | - |